GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BATM Advanced Communications Ltd (OTCPK:BVCLF) » Definitions » Long-Term Debt

BATM Advanced Communications (BATM Advanced Communications) Long-Term Debt : $1.3 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is BATM Advanced Communications Long-Term Debt?

BATM Advanced Communications's Long-Term Debt for the quarter that ended in Dec. 2023 was $1.3 Mil.

BATM Advanced Communications's quarterly Long-Term Debt declined from Dec. 2022 ($2.0 Mil) to Jun. 2023 ($0.0 Mil) but then increased from Jun. 2023 ($0.0 Mil) to Dec. 2023 ($1.3 Mil).

BATM Advanced Communications's annual Long-Term Debt increased from Dec. 2021 ($1.4 Mil) to Dec. 2022 ($2.0 Mil) but then declined from Dec. 2022 ($2.0 Mil) to Dec. 2023 ($1.3 Mil).

BATM Advanced Communications Long-Term Debt Historical Data

The historical data trend for BATM Advanced Communications's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BATM Advanced Communications Long-Term Debt Chart

BATM Advanced Communications Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 0.68 1.36 2.00 1.33

BATM Advanced Communications Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.36 0.01 2.00 - 1.33

BATM Advanced Communications  (OTCPK:BVCLF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

BATM Advanced Communications Long-Term Debt Related Terms

Thank you for viewing the detailed overview of BATM Advanced Communications's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

BATM Advanced Communications (BATM Advanced Communications) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BATM Advanced Communications Ltd (OTCPK:BVCLF) » Definitions » Long-Term Debt
Comparable Companies
LSE:SPEC LSE:CNSL LSE:TSTL ISRG XPAR:EL BDX TSE:7741 XSWX:ALC OCSE:COLO B RMD WST XPAR:DIM TSE:4543 XSWX:STMN BAX COO HOLX TSE:7733 XTER:AFX TSE:6869
Traded in Other Exchanges
BVC:Israel BVCl:UK BVC.GB:UK BVC:UK BAV:Germany
Address
4 Ha’harash Street, P.O.B. 7318, Nave Ne'eman Industrial Area, Hod Hasharon, ISR, 4524075
Website
https://www.batm.com
BATM Advanced Communications Ltd is an Israel-based technology company. The company organizes its business operations into two divisions: Networking & Cyber Division and Biomedical Division. Networking and Cyber Division mostly includes the research and development, production, and marketing of data communication products in the field of local and wide area networks and premises management systems. Bio-Medical Division is engaged in the research and development, production, marketing, and distribution of medical products, primarily laboratory diagnostic equipment and sterilization equipment. The majority of its revenue is derived from Biomedical Division. Its geographical segments are the United States of America, Israel, and Europe.